Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucilla Parnetti

Showing results (181-190 of 283) with videos related to

Pageof 29
Sort By:
Journal of Neurology|May 27, 2019
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosisLorenzo Gaetani, Nicola Salvadori, Viviana Lisetti, et al.
Alzheimer'S Research & Therapy|July 29, 2017
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementiaDavide Chiasserini, Leonardo Biscetti, Paolo Eusebi, et al.
Neuroradiology|September 12, 2020
Changes of olfactory tract in Parkinson's disease: a DTI tractography studyPasquale Nigro, Andrea Chiappiniello, Simone Simoni, et al.
Frontiers in Aging Neuroscience|April 19, 2014
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's DiseaseLucilla Parnetti, Lucia Farotti, Paolo Eusebi, et al.
Epilepsia|June 18, 2024
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort studyMichela Giustozzi, Carmen Calvello, Paolo Eusebi, et al.
Alzheimer'S Research & Therapy|March 24, 2019
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's diseaseCarla M Startin, Nicholas J Ashton, Sarah Hamburg, et al.
Journal of Alzheimer'S Disease : JAD|September 19, 2022
A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other DementiasKatharina Bolsewig, Yanaika S Hok-A-Hin, Federica N Sepe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 23, 2016
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progressionNour K Majbour, Nishant N Vaikath, Paolo Eusebi, et al.
Amino Acids|February 22, 2021
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's diseaseTommaso Nuzzo, Andrea Mancini, Mattia Miroballo, et al.
Multiple Sclerosis and Related Disorders|February 21, 2025
Cerebrospinal fluid interferon-γ and development of depression in multiple sclerosisGiulia Menculini, Silvia Sperandei, Lorenzo Gaetani, et al.
Pageof 29

Showing results (181-190 of 283) with videos related to

Sort By:
Pageof 29
Journal of Neurology|May 27, 2019
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosisLorenzo Gaetani, Nicola Salvadori, Viviana Lisetti, et al.
Alzheimer'S Research & Therapy|July 29, 2017
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementiaDavide Chiasserini, Leonardo Biscetti, Paolo Eusebi, et al.
Neuroradiology|September 12, 2020
Changes of olfactory tract in Parkinson's disease: a DTI tractography studyPasquale Nigro, Andrea Chiappiniello, Simone Simoni, et al.
Frontiers in Aging Neuroscience|April 19, 2014
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's DiseaseLucilla Parnetti, Lucia Farotti, Paolo Eusebi, et al.
Epilepsia|June 18, 2024
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort studyMichela Giustozzi, Carmen Calvello, Paolo Eusebi, et al.
Alzheimer'S Research & Therapy|March 24, 2019
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's diseaseCarla M Startin, Nicholas J Ashton, Sarah Hamburg, et al.
Journal of Alzheimer'S Disease : JAD|September 19, 2022
A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other DementiasKatharina Bolsewig, Yanaika S Hok-A-Hin, Federica N Sepe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 23, 2016
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progressionNour K Majbour, Nishant N Vaikath, Paolo Eusebi, et al.
Amino Acids|February 22, 2021
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's diseaseTommaso Nuzzo, Andrea Mancini, Mattia Miroballo, et al.
Multiple Sclerosis and Related Disorders|February 21, 2025
Cerebrospinal fluid interferon-γ and development of depression in multiple sclerosisGiulia Menculini, Silvia Sperandei, Lorenzo Gaetani, et al.
Pageof 29